Malignant Epithelial Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-11-07
Clinical Trial Update: Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors [EARLY_Phase 1]
An early-phase trial is evaluating the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte …